Next report date
Report period
Q1 2024
EPS estimate
—
Revenue estimate
—
−11.0912USD
−8.63 MUSD
1.10 M
About Ampio Pharmaceuticals, Inc.
Sector
CEO
Michael A. Martino
Headquarters
Englewood
Website
Employees (FY)
6
Founded
2008
FIGI
BBG000JKSJP5
Ampio Pharmaceuticals, Inc. operates as a biopharmaceutical company. The firm engages in the development of therapies to treat prevalent inflammatory conditions. Its product pipeline includes new uses for approved drugs and new molecular entities for important therapeutic areas, including metabolic disease, eye disease, kidney disease, inflammation and sexual dysfunction and CNS disease. The company was founded by David Bar-Or in December 2008 and is headquartered in Englewood, CO.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of AMPE is 0.3500 USD — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Ampio Pharmaceuticals, Inc. stocks are traded under the ticker AMPE.
Ampio Pharmaceuticals, Inc. is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
AMPE stock is 0% volatile and has beta coefficient of 2.01. Check out the list of the most volatile stocks — is Ampio Pharmaceuticals, Inc. there?
AMPE earnings for the last quarter are −9.00 USD per share, whereas the estimation was −6.00 USD resulting in a −50.00% surprise. The estimated earnings for the next quarter are −6.00 USD per share. See more details about Ampio Pharmaceuticals, Inc. earnings.
Yes, you can track Ampio Pharmaceuticals, Inc. financials in yearly and quarterly reports right on TradingView.
AMPE stock hasn't changed in a week, the month change is a 55.70% fall, over the last year Ampio Pharmaceuticals, Inc. has showed a 59.82% increase.
AMPE net income for the last quarter is −2.05 M USD, while the quarter before that showed −1.23 M USD of net income which accounts for −67.13% change. Track more Ampio Pharmaceuticals, Inc. financial stats to get the full picture.
Today Ampio Pharmaceuticals, Inc. has the market capitalization of 397.38 K, it has increased by 13.67% over the last week.
No, AMPE doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, AMPE shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Ampio Pharmaceuticals, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 26, 2024, the company has 6.00 employees. See our rating of the largest employees — is Ampio Pharmaceuticals, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Ampio Pharmaceuticals, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Ampio Pharmaceuticals, Inc. stock shows the strong sell signal. See more of Ampio Pharmaceuticals, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.